Characterization of the β-adrenoceptor subtype involved in mediation of glucose transport in L6 cells

British Journal of Pharmacology

Volumn 137, Issue 1, 2002, Pages 9-18

  Nevzorova, Julia ^a   Bengtsson, Tore ^a   Evans, Bronwyn A ^a   Summers, Roger J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cyclic AMP; Glucose transport; Insulin; Phosphatidylinositol 3 kinase; adrenoceptor

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUCLADESINE; FORSKOLIN; GLUCOSE; INSULIN; ISOPRENALINE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROPRANOLOL; WORTMANNIN; ZINTEROL;

ANIMAL CELL; ARTICLE; CALCULATION; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; GLUCOSE ASSAY; GLUCOSE TRANSPORT; MYOBLAST; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION; SKELETAL MUSCLE;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANDROSTADIENES; ANIMALS; BIOLOGICAL TRANSPORT; BUCLADESINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; GLUCOSE; INSULIN; MUSCLE, SKELETAL; RATS; RECEPTORS, ADRENERGIC, BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0036729531     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704845     Document Type: Article

References (33)

1. Effect of a beta 3-adrenergic agonist, BRL35135A, on glucose uptake in rat skeletal muscle in vivo and in vitro
2. Identification of a novel gene encoding an insulin-responsive glucose transporter protein
3. BRL37344, but not CGP12177, stimulates fuel oxidation by soleus muscle in vitro
4. 3-adrenoceptor in human adipose tissue, atrium and skeletal muscle
5. 3 receptor knockout mice
6. Insulin and insulin-like growth factor I receptors utilise different G protein signalling components
7. The effect of insulin on the disposal of intravenous glucose
8. Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines
9. Dexamethasone stimulates the expression of GLUT1 and GLUT4 proteins via different signalling pathways in L6 skeletal muscle cells
10. Glucose transporter expression in human skeletal muscle fibres
11. β-adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo
12. Four β-adrenoceptor subtypes in the mammalian heart
13. Inhibition by forskolin of insulin-stimulated glucose transport in L6 muscle cells
14. Biphasic effects of the beta-adrenoceptor agonist. BRL 37344, on glucose utilization in rat isolated skeletal muscle
15. Acute effects of the beta 3-adrenoceptor agonist. BRL 35135, on tissue glucose utilisation
16. 3-selective antagonists, aryloxypropanolaminotetralins
17. 2-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor
18. Expanding roles for β-arrestins as scaffolds and adapters in GPCR signaling and trafficking
19. Differential expression of the GLUT1 and GLUT4 glucose transporters during differentiation of L6 muscle cells
20. Up-regulation of uncoupling proteins by β-adrenergic stimulation in L6 myotubes
21. 3-agonists in brown adipocyte primary culture
22. 3-adrenoceptors in rat ileum
23. 3-adrenoceptors
24. 8-Bromo-cAMP inhibits glucose transport activity in mouse placental cells in culture
25. Effect of insulin on GLUT-4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives
26. Inhibition of 3-O-methylglucose transport in human erythrocytes by forskolin
27. Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: Implications for glucose metabolism
28. Use of pharmacological agents in elucidating the mechanisms of insulin action
29. The beta3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin
30. Dual effects of forskolin on glucose utilization in cultured fibroblasts, as observed with the use of glucose analogs
31. Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells
32. Insulin activation of mitogen-activated protein kinases Erk 1,2 is amplified via beta-adrenergic receptor expression and requires the integrity of the Tyr350 of the receptor
33. 3-adrenoceptor agonist, in yellow KK mice